Yüklüyor......
Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID‐19
BACKGROUND: Hydroxychloroquine (HCQ) and azithromycin (AZM) are widely used in off‐label treatment of novel coronavirus disease (COVID‐19). However, cardiac safety of these drugs is still controversial in COVID‐19. Therefore, we aimed to evaluate association of HCQ or HCQ + AZM treatment regimens, c...
Kaydedildi:
| Yayımlandı: | Int J Clin Pract |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7883090/ https://ncbi.nlm.nih.gov/pubmed/33280207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.13896 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|